- Home
- PRGS vs INVA Comparison
PRGS vs INVA Comparison
Compare PRGS & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRGS | INVA |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 1991 | 2004 |
Fundamental Metrics
Financial Performance| Metric | PRGS | INVA |
|---|---|---|
| Price | $42.30 | $19.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $67.00 | $36.80 |
| AVG Volume (30 Days) | 521.3K | ★ 925.3K |
| Earning Date | 01-20-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | 1.09 | ★ 1.52 |
| Revenue | ★ $940,126,000.00 | $388,521,000.00 |
| Revenue This Year | $32.42 | $13.23 |
| Revenue Next Year | $1.44 | $8.58 |
| P/E Ratio | $38.50 | ★ $12.89 |
| Revenue Growth | ★ 31.41 | 10.14 |
| 52 Week Low | $39.00 | $16.52 |
| 52 Week High | $65.50 | $22.76 |
Technical Indicators
Market Signals| Indicator | PRGS | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 42.40 |
| Support Level | $39.60 | $19.26 |
| Resistance Level | $42.90 | $20.23 |
| Average True Range (ATR) | 1.11 | 0.49 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 65.19 | 34.65 |
Price Performance
Historical ComparisonAbout PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.